IT202200002000A1 - Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale - Google Patents
Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale Download PDFInfo
- Publication number
- IT202200002000A1 IT202200002000A1 IT102022000002000A IT202200002000A IT202200002000A1 IT 202200002000 A1 IT202200002000 A1 IT 202200002000A1 IT 102022000002000 A IT102022000002000 A IT 102022000002000A IT 202200002000 A IT202200002000 A IT 202200002000A IT 202200002000 A1 IT202200002000 A1 IT 202200002000A1
- Authority
- IT
- Italy
- Prior art keywords
- active ingredient
- oral composition
- poorly absorbable
- intestinal level
- liposomal
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000002000A IT202200002000A1 (it) | 2022-02-04 | 2022-02-04 | Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000002000A IT202200002000A1 (it) | 2022-02-04 | 2022-02-04 | Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200002000A1 true IT202200002000A1 (it) | 2023-08-04 |
Family
ID=81648824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000002000A IT202200002000A1 (it) | 2022-02-04 | 2022-02-04 | Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202200002000A1 (it) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0265116B1 (en) * | 1986-10-13 | 1998-03-11 | FIDIA S.p.A. | Cross-linked esters of hyaluronic acid |
CA3025208A1 (en) * | 2016-05-24 | 2017-11-30 | Bol Pharma Ltd. | Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases |
WO2018138221A1 (en) * | 2017-01-26 | 2018-08-02 | Beauty System Pharma S.R.L. | Hyaluronic acid cross-linked with natural or semi-synthetic crosslinking agents |
-
2022
- 2022-02-04 IT IT102022000002000A patent/IT202200002000A1/it unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0265116B1 (en) * | 1986-10-13 | 1998-03-11 | FIDIA S.p.A. | Cross-linked esters of hyaluronic acid |
CA3025208A1 (en) * | 2016-05-24 | 2017-11-30 | Bol Pharma Ltd. | Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases |
WO2018138221A1 (en) * | 2017-01-26 | 2018-08-02 | Beauty System Pharma S.R.L. | Hyaluronic acid cross-linked with natural or semi-synthetic crosslinking agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50212546D1 (de) | Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung | |
CL2004000382A1 (es) | Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6. | |
MA55557A (fr) | Formes solides d'un inhibiteur de bêta-lactamases administré par voie orale et leurs utilisations | |
DE602004011398D1 (de) | Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779 | |
EA202190621A1 (ru) | Фармацевтическая композиция, содержащая антитромбоцитарное средство и ингибитор секреции желудочной кислоты | |
IT202200002000A1 (it) | Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale | |
ECSP055625A (es) | Profarmaco inhibidor de beta-lactamasa | |
ES2981041T3 (es) | Formulación oral sólida de utidelona | |
MX2020008230A (es) | Derivados de ester butanoico sustituido con bisfenilo como inhibidores de nep. | |
JP1772017S (ja) | タオル | |
JP1770478S (ja) | 衛生マスク | |
JP1770477S (ja) | 衛生マスク | |
JP1762594S (ja) | 衛生マスク | |
JP1762595S (ja) | 衛生マスク | |
JP1740191S (ja) | 衛生マスク | |
JP1735670S (ja) | 衛生マスク | |
JP1730756S (ja) | 衛生用マスク | |
JP1725778S (ja) | 衛生用マスク | |
JP1725739S (ja) | 衛生用マスク | |
JP1725738S (ja) | 衛生用マスク | |
JP1723540S (ja) | 衛生用マスク | |
JP1723539S (ja) | 衛生用マスク | |
JP1723538S (ja) | 衛生用マスク | |
JP1722551S (ja) | 衛生用マスク | |
JP1716715S (ja) | 衛生用マスク |